Preclinical studies support endogenous opioid system involvement in alcohol
reinforcement and consumption; however, recent clinical trials and human l
aboratory studies have provided mixed findings of the effects of naltrexone
(a non-selective opioid antagonist) on alcohol responses. This study used
a within-subject design (n=23) to investigate naltrexone effects (0, 50 and
100 mg qd) on subjective and psychomotor responses to alcohol (none, moder
ate, high) in heavy drinkers. Before alcohol administration, subjects repor
ted decreased desire to drink alcohol when maintained on 50 mg compared wit
h placebo naltrexone. Following alcohol administration, active naltrexone s
ignificantly increased subjective ratings of sedative, and unpleasent/sick
effects and decreased ratings of liking, best effects and desire to drink.
Naltrexone generally did not alter subjective or objective indicators of dr
unkenness. Finally, high doses of naltrexone and alcohol interacted to prod
uce the greatest decreases in liking and best effects. Findings support the
role of endogenous opioids as determinants of alcohol's effects and sugges
ts that naltrexone may be particularly clinically useful in those treatment
patients who continue to drink heavily. (C) American College of Neuropsych
opharmacology. Pulished by Elsevier Science Inc.